Dr. Uribe is Leader of Clinical Nuclear Medicine Physics (Provincial Operations) at BC Cancer and Clinical Assistant Professor at UBC Radiology. He has overseen the opening of 2 new PET/CT centres in BC. He co-leads the Qurit Research Program, and his research focuses on quantitative imaging and dosimetry for radiopharmaceutical therapies and is actively looking into how artificial intelligence can aid in the path to personalized theranostics.
He has made significant contributions to implementation of radiopharmaceutical therapies in Canada, internal radiation dosimetry, motion correction in PET, optimization of injected activities for PET imaging, and selection of new radiopharmaceuticals for clinical translation.
Internationally, he is a member of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Dosimetry Task force, and an elected board member of the SNMMI Therapy Center of Excellence. He leads global efforts for standardization of dosimetry protocols; e.g. the SNMMI 177Lu Dosimetry Challenge. Carlos is also a member of the Committee on Medical Internal Radiation Dose (MIRD) which develops standards for calculation of internal dose in nuclear medicine.
Medical Imaging Physicist
Provincial PET Functional Imaging, BC Cancer
Associate Scientist
Integrative Oncology, BC Cancer Research Institute
Clinical Assistant Professor
Department of Radiology, UBC
“Clinical Molecular Imaging and Therapy”